Type
Internal restructuring
Country
Germany
Region
Baden-W├╝rttemberg; Karlsruhe; Mannheim
Location of affected unit(s)
Mannheim
Sector
Professional Services
Scientific, Architectural And Engineering Technical Activities
Scientific Research And Development
72.1 - Research and experimental development on natural sciences and engineering

60 jobs
Number of planned job losses
Job loss
Announcement Date
19 July 2012
Employment effect (start)
Foreseen end date

Description

Swiss pharmaceuticals group Roche will cut 60 out of 310 research and development jobs at its Mannheim plant. This is due to a reorganisation of Roche's global research and development activities in the diabetes segment.

While Mannheim will become the centre for insulin pumps and continuous blood glucose monitoring, the development of blood sugar meters will be centralized in Indianapolis, USA, where the reorganization will affect 40 posts.

A timeframe for the redundancies is not yet fixed. Talks with the German works council are yet to be held, although it is stated that direct dismissals are to be prevented.

This follows earlier redundancies at the Mannheim plant, where Roche announced the cutting of 150 jobs in March 2012 (see here).


Sources

  • 19 July 2012: morgenweb

Citation

Eurofound (2012), Roche, Internal restructuring in Germany, factsheet number 73980, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/73980.